Taxol Epirubicin Cyclophosphamide Herceptin Neoadjuvant (TECHNO)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Epirubicin / Cyclophosphamide in combination with Paclitaxel/Trastuzumab, followed by postoperative Trastuzumab
Sponsor: German Breast Group
Collaborators: AGO Study Group